BioHealth News Archive
Baltimore medical device firm Renalert wins $25,000 prize at Beta City – Baltimore Business Journal
A Baltimore medical device firm that aims to prevent kidney injury was awarded the $25,000 grand prize in the Beta City Venture Capital Pitch…
Read More
Emergent BioSolutions Receives NIH Research Grant to Further Develop AP007, Its Development Stage Sustained-Release Nalmefene Treatment for Opioid Use Disorder NYSE:EBS
GAITHERSBURG, Md., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a research grant awarded by the National Institute on…
Read More
NIH center struggles to speed new therapies | Science
In September 2012, when National Institutes of Health (NIH) neurologist Chris Austin took charge of a new translational science center, he faced a host…
Read More
Emmes Ranked as a Top Private Company
ROCKVILLE, Md., Sept. 30, 2019 /PRNewswire/ -- Emmes today announced that it was ranked as one of the 100 largest private companies in the…
Read More
Six NICU Device Innovators Share $150K in Awards at 7th Annual Pediatric Device Innovation Symposium
WASHINGTON, Sept. 23, 2019 /PRNewswire/ -- Children's National Hospital and the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announce the six winners of…
Read MoreKaloCyte Relocates to Downtown Baltimore as Co-Founders Join University of Maryland Faculty – KaloCyte
BALTIMORE, Sept. 23, 2019 /PRNewswire/ — KaloCyte, a preclinical-stage healthcare biotechnology company developing a synthetic, bio-inspired red blood cell substitute for use in settings…
Read More
Our Senior Consultant Cluster Lead Boaz Van Driel just returned from his fruitful visit
Our Senior Consultant and Cluster Lead Boaz Van Driel just returned from his fruitful visit with our collaborators BioHealth Innovation, Inc. This trip was…
Read More
LumaCyte Primed for Significant Global Growth: CE Mark Opens European Market | Business Wire
CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--LumaCyte, an advanced research and bioanalytics instrumentation company headquartered in Charlottesville, VA, announces the third doubling of their manufacturing and laboratory space.…
Read More
Facility Logix Highlights Firm’s Significant Growth as It Celebrates 15th Anniversary – Facility Logix
Burtonsville, MD – September 19, 2019 – Facility Logix, a life sciences consulting firm providing best-in-class customized facility solutions and novel approaches to facility…
Read More
Alexandria Real Estate Bets on Innovation Clusters
The properties are rented by primarily high quality tenants and the cash flow is well supported by long term, triple net lease contracts. These…
Read More
Serial Entrepreneurs of the Biohealth Capital Region · BioBuzz
A strong group of entrepreneurs ready and willing to innovate, fund and lead new bioscience companies is essential to the creation and sustainability of…
Read More
College launches new student cohort research study “Mason: Health Starts Here” at the Population Health Center | CHHS
On September 17, the College of Health and Human Services kicked-off “Mason: Health Starts Here,” a first-of-its-kind transdisciplinary student cohort study to understand and…
Read More
Alexandria Real Estate Equities, Inc. Selected by the City of Seattle to Transform the Mercer Mega Block Into a Community-Oriented, Amenity-Driven Mixed-Use Campus Uniquely Designed to Stimulate Collaboration and Innovation
Alexandria has been at the vanguard of Seattle's growing commercial life science ecosystem since entering the Seattle market in 1996 and is committed to…
Read More
Saving Lives with Robots – YouTube
One of the biggest dangers for trauma patients during the ambulance ride is undiagnosed, internal hemorrhagic bleeding. It’s currently undetectable with methods available on…
Read More
Top 10 U.S. Biopharma Clusters – BioHeath Capital Region Strengthens Its Position As It Improves Its Performance In Several Categories
After a generation spent shaping the growth and development of biopharma clusters, Alexandria Real Estate Equities executive chairman and founder Joel Marcus recently spoke…
Read More